There were 508 press releases posted in the last 24 hours and 170,650 in the last 365 days.

Results announcement for fourth quarter 2013

GSK announces core EPS of 112.2p and dividend of 78p

  • Core EPS of 112.2p (+4% CER) and dividend of 78p (+5%)
  • £5.2 billion of cash returned to shareholders through 5% increase in 2013 dividend to 78p, (Q4 23p) and repurchase of £1.5 billion of shares
  • Exceptional year for RD delivery with approvals forsix major products andfive additional regulatory filings completed
  • New product launches strengthen businesses in Respiratory, Vaccines, HIV and Oncology

Pipeline opportunity remains substantial with Phase III data forsix potential new drugs and vaccines and aroundten NME Phase III starts across 2014 and 2015.

View full Q4 2013 results (PDF)

More details with CEO and CFO interview available in the quarterly results section of this website.

Distribution channels: Companies

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.